PPT-Acute myeloid leukemia (AML)
Author : LoudAndProud | Published Date : 2022-07-27
Justyna Rybka Department of Haematology Blood Neoplasms and Bone Marrow Transplantation Wroclaw Medical University Klinika Hematologii Nowotworów Krwi i Transplantacji
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Acute myeloid leukemia (AML)" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Acute myeloid leukemia (AML): Transcript
Justyna Rybka Department of Haematology Blood Neoplasms and Bone Marrow Transplantation Wroclaw Medical University Klinika Hematologii Nowotworów Krwi i Transplantacji Szpiku AML is a heterogeneous haematological malignancy of the myeloid blood cells. I. n The name of God. . CD 117, C- kit. CD117 is a 145 . kD. protein tyrosine . kinase. also known as c-Kit.. Receptor for stem cell factor . or c-Kit . ligand. .. . CD117 is expressed on . pluripotent. Rebecca L. King, . Gerald Wertheim, Michele E. Paessler. The Children’s Hospital of Philadelphia. Perelman School of Medicine at the University of Pennsylvania. Philadelphia, PA. Clinical History. 13 year old boy. Cedar Mountain post acute rehabilitation center provide a therapeutic environment for our residents Yucaipa. Individualized treatment programs are developed with the interdisciplinary team of nursing, social services, Healthcare and dietary in consultation with your physicians. proceedings from the live CME event and may include . the use of trade names and other raw, unedited content. . Module 10: . Acute Myeloid Leukemia . Drs Stone and . Pollyea. . Do you have any patients in your practice with.... adolescents: recommendations from an international expert panel –BFM . blood- 2012 ,120: 3187-3205. . Absence . of published . recommendations specific . for pediatric . AML . motivated an international . Dr. . B.V.Vydehi. M.D. PROFESSOR OF PATHOLOGY. NARAYANA MEDICAL COLLEGE,NELLORE. Uncontrolled & abnormal proliferation of one of white blood cells & their precursors in the bone marrow and peripheral blood. Arif Ali Awan – R2 JGH. November 27. th. , 2014. IM Teaching. Disclaimer. Just a Resident. Case. 52F Nurse, 3 sisters. PMHx. : HTN, hysterectomy. Meds: . Hctz. 12.5; NKDA. No family history. Presents with 6 week history of intermittent fever (. PROGNOSTIC FACTORS. Although the first published reports of leukemia occurred in 1845 by Bennett and Virchow, the lack of refined diagnostic methodology limited the distinction between myeloid and lymphoid acute leukemia, With the development of refined staining techniques, followed by microscopy and histochemical staining by the mid-20th century, this distinction was . BSW00073 / OK 11 - ONC - 152 1 July , 2011 Fact Sheet Leukemia is a cancer that begins in the bone marrow ( the soft inner part of some bones), but in most cases, moves into the blood. It can t hen s signicance dicult to ascertain []. ere are numerous other common cytogenetic ndings that are not routinely used for risk stratication, including 11q23 rearrangements, despite their prevalence in Sofia Kolovich. 1. , Allison LaRocco. 1. , . Malith. Karunasiri. 1. , Girish Rajgolikar. 1. , Allison Walker. 1. , Ramiro Garzon. 1. , Marius Bill. 1. , Adrienne Dorrance. 1. . 1. The Ohio State University Comprehensive Cancer Center, Division of Hematology, The Ohio State University, Columbus, OH 43210.. Goals. Incidence. Etiology. Diagnosis. Types/Classification. Treatment. Primary Care Pearls. Incidence. 30% of all cancers in childhood. Peak incidence 2-5 years of age. males > females. Caucasian > African American. . A. ccumulation of abnormal blasts (. I. mmature precursors of WBC). . in bone marrow and blood leading to:. . 1- Bone marrow failure. . (. anemia ,neutropenia & thrombocytopenia). . 2- Organ infiltration . Jayllex Mills,. PharmD Candidate. AML Background. Hematologic malignancy affecting the blood and bone marrow. Result of proliferation of abnormal myeloid stem cell derivatives and interference of normal blood cell production.
Download Document
Here is the link to download the presentation.
"Acute myeloid leukemia (AML)"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents